During the past decade, Hiratsuka kyosai hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hiratsuka kyosai hospital" #1 collaborator was "NPO International TRI Network" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hiratsuka kyosai hospital" are "Acute Myocardial Infarction" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Hiratsuka kyosai hospital" in a lesser frequency.

Most popular intervention types in "Hiratsuka kyosai hospital" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biolimus A9 eluting stents" (1 trials), "Cypher stent" (1 trials), "TAXUS stent" (1 trials) and "uncoated stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hiratsuka kyosai hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hiratsuka kyosai hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hiratsuka kyosai hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hiratsuka kyosai hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".